Security key
61225M102
Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GLUE)
CUSIP: 61225M102
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 84,039,109
- Total 13F shares
- 41,325,746
- Share change
- +972,645
- Total reported value
- $314,458,629
- Put/Call ratio
- 2.6%
- Price per share
- $7.61
- Number of holders
- 66
- Value change
- +$7,213,706
- Number of buys
- 31
- Number of sells
- 27
Report period
Q4 2022
Institutions
66
Top holders
10
GLUE full security history
Newer quarter: Q1 2023
Previous quarter: Q3 2022
Monte Rosa Therapeutics, Inc. SEC filings
Monte Rosa Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 61225M102
Recent filing periods:
Top shareholders of GLUE - Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| NEA Management Company, LLC |
13F
|
Company |
9.2%
|
7,703,205
|
$62,935,000 | — | 30 Sep 2022 | |
| FMR LLC |
13F
|
Company |
7.4%
|
6,204,974
|
$50,695,000 | — | 30 Sep 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
4.5%
|
3,763,386
|
$30,747,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.1%
|
3,470,232
|
$28,352,000 | — | 30 Sep 2022 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
4%
|
3,363,333
|
$27,478,000 | — | 30 Sep 2022 | |
| Cormorant Asset Management, LP |
3/4/5
13F
|
Former 10% Owner · Company |
3.6%
from 13F
|
3,202,200
|
$60,841,800 | — | 28 Jun 2021 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2.3%
|
1,924,778
|
$15,726,000 | — | 30 Sep 2022 | |
| Aisling Capital Management LP |
13F
|
Company |
1.8%
|
1,472,331
|
$12,029,000 | — | 30 Sep 2022 | |
| Alphabet Inc. |
13F
|
Company |
1.7%
|
1,464,015
|
$11,961,000 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.7%
|
1,407,667
|
$11,501,000 | — | 30 Sep 2022 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
1.4%
|
1,214,572
|
$9,923,000 | — | 30 Sep 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.1%
|
952,956
|
$7,785,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.63%
|
530,112
|
$4,331,000 | — | 30 Sep 2022 | |
| Casdin Capital, LLC |
13F
|
Company |
0.61%
|
510,882
|
$4,174,000 | — | 30 Sep 2022 | |
| Woodline Partners LP |
13F
|
Company |
0.6%
|
502,411
|
$4,105,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.58%
|
484,571
|
$3,959,000 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.3%
|
248,150
|
$2,027,000 | — | 30 Sep 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.25%
|
213,215
|
$1,742,000 | — | 30 Sep 2022 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.17%
|
140,854
|
$1,104,000 | — | 30 Sep 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.16%
|
132,647
|
$1,083,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.15%
|
122,004
|
$996,000 | — | 30 Sep 2022 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.14%
|
117,455
|
$960,000 | — | 30 Sep 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.13%
|
106,327
|
$869,000 | — | 30 Sep 2022 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.12%
|
103,349
|
$814,355 | — | 30 Sep 2022 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.12%
|
99,202
|
$810,481 | — | 30 Sep 2022 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.11%
|
91,615
|
$748,000 | — | 30 Sep 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.1%
|
87,632
|
$716,000 | — | 30 Sep 2022 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.1%
|
85,798
|
$700,000 | — | 30 Sep 2022 | |
| Sarasin & Partners LLP |
13F
|
Company |
0.08%
|
65,081
|
$532,000 | — | 30 Sep 2022 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.06%
|
50,222
|
$410,000 | — | 30 Sep 2022 | |
| Swiss National Bank |
13F
|
Company |
0.05%
|
43,900
|
$359,000 | — | 30 Sep 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.05%
|
42,962
|
$351,000 | — | 30 Sep 2022 | |
| Trexquant Investment LP |
13F
|
Company |
0.05%
|
41,600
|
$340,000 | — | 30 Sep 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.04%
|
33,294
|
$272,000 | — | 30 Sep 2022 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.04%
|
32,406
|
$265,000 | — | 30 Sep 2022 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.03%
|
28,410
|
$232,000 | — | 30 Sep 2022 | |
| CORNERCAP INVESTMENT COUNSEL INC |
13F
|
Company |
0.03%
|
28,192
|
$230,000 | — | 30 Sep 2022 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.03%
|
27,382
|
$224,000 | — | 30 Sep 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.03%
|
25,929
|
$212,000 | — | 30 Sep 2022 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.03%
|
23,492
|
$192,000 | — | 30 Sep 2022 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.03%
|
22,166
|
$181,000 | — | 30 Sep 2022 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.02%
|
20,357
|
$166,000 | — | 30 Sep 2022 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.02%
|
19,084
|
$156,000 | — | 30 Sep 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
19,043
|
$156,000 | — | 30 Sep 2022 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.02%
|
19,031
|
$155,000 | — | 30 Sep 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
18,916
|
$155,000 | — | 30 Sep 2022 | |
| Jump Financial, LLC |
13F
|
Company |
0.02%
|
18,200
|
$149,000 | — | 30 Sep 2022 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.02%
|
18,157
|
$148,343 | — | 30 Sep 2022 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.02%
|
16,500
|
$131,000 | — | 30 Sep 2022 | |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
15,130
|
$124,000 | — | 30 Sep 2022 |
Institutional Holders of Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GLUE) as of Q4 2022
As of 31 Dec 2022,
Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GLUE) was held by
66 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,325,746 shares.
The largest 10 holders included
NEA Management Company, LLC, FMR LLC, Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., Cormorant Asset Management, LP, T. Rowe Price Investment Management, Inc., Aisling Capital Management LP, Alphabet Inc., and VANGUARD GROUP INC.
This page lists
66
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
70
Q4 2022 holders
66
Holder diff
-4
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.